Vir Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65.5	68.56	74.21	86.18	1,616	1,095
Revenue Growth (YoY)	213.96%	-7.61%	-13.89%	-94.67%	47.50%	1334.40%
Cost of Revenue	0.03	0.03	0.85	2.77	146.32	65.87
Gross Profit	65.47	68.53	73.36	83.42	1,469	1,030
Selling, General & Admin	91.47	92.07	119.03	174.44	161.76	160.79
Research & Development	446.24	455.97	506.5	579.72	474.65	448.01
Other Operating Expenses	-0.17	-0.18	35	13.56	-	-
Total Operating Expenses	537.54	547.86	660.53	767.72	636.41	608.8
Operating Income	-472.07	-479.33	-587.17	-684.31	833.07	420.75
Interest Income	35.14	40.24	71.81	86.99	28.09	0.44
Other Non-Operating Income (Expense)	-5.41	1.32	-7.75	-30.88	-106.88	128.61
Total Non-Operating Income (Expense)	29.73	41.56	64.06	56.11	-78.79	129.05
Pretax Income	-442.35	-437.77	-523.11	-628.19	754.28	549.8
Provision for Income Taxes	0.37	0.22	-1.15	-13.08	238.44	21.22
Net Income	-442.72	-437.99	-521.96	-615.12	515.84	528.58
Minority Interest in Earnings	-	-	-	0.06	-	-
Net Income to Common	-442.72	-437.99	-521.96	-615.06	515.84	528.58
Net Income Growth	-	-	-	-	-2.41%	-
Shares Outstanding (Basic)	141	139	136	134	133	130
Shares Outstanding (Diluted)	141	139	136	134	135	133
Shares Change (YoY)	3.07%	1.67%	1.58%	-0.50%	1.03%	11.98%
EPS (Basic)	-3.13	-3.16	-3.83	-4.59	3.89	4.07
EPS (Diluted)	-3.13	-3.16	-3.83	-4.59	3.83	3.96
EPS Growth	-	-	-	-	-3.28%	-
Free Cash Flow	-448.98	-396.61	-453.65	-800.36	1,595	-69.41
Free Cash Flow Per Share	-3.18	-2.86	-3.33	-5.97	11.83	-0.52
Gross Margin	99.96%	99.96%	98.86%	96.79%	90.94%	93.99%
Operating Margin	-720.77%	-699.18%	-791.27%	-794.04%	51.56%	38.41%
Profit Margin	-675.96%	-638.88%	-703.40%	-713.76%	31.92%	48.25%
FCF Margin	-685.52%	-578.52%	-611.35%	-928.71%	98.73%	-6.34%
EBITDA	-460.45	-467.65	-572.61	-664.85	839.85	426.56
EBITDA Margin	-703.03%	-682.14%	-771.65%	-771.47%	51.98%	38.94%
EBIT	-472.07	-479.33	-587.17	-684.31	833.07	420.75
EBIT Margin	-720.77%	-699.18%	-791.27%	-794.04%	51.56%	38.41%
Effective Tax Rate	-0.08%	-0.05%	0.22%	2.08%	31.61%	3.86%

SEC Filings: 10-K · 10-Q